Background: Junctional hemorrhage is a potentially preventable cause of death. The Abdominal Aortic and Junctional Tourniquet (AAJT) compresses major vascular structures and arrests blood flow in exsanguinating hemorrhage. In a human model, the AAJT was effective in stopping blood flow in the femoral arteries via compression of the distal aorta. This study compares the ability of AAJT and Combat Gauze (CG) to stop hemorrhagic bleeding from a hemicorporectomy in a swine model.
Method: Six anesthetized swine were used. Carotid arterial catheters were placed for continuous mean arterial pressure (MAP) readings. A hemicorporectomy was accomplished with a blade lever device by cutting the animal through both femoral heads transecting the proximal iliac arteries and veins. Hemorrhage control was attempted with the AAJT and regular Kerlix gauze or CG packing and direct pressure followed by Kerlix gauze placed over the CG. The primary outcome measure was survival at 60 minutes.
Results: The 60-minute survival was 100% for the AAJT and 0% for the CG group. During the 60-minute monitoring period, only one CG animal achieved hemostasis. For the AAJT group, the mean time to hemostasis was 30 seconds. Initial MAP was higher in the AAJT group (mean, 87mmHg) than the CG group (mean, 70mmHg). The mean 60-minute MAP was 73mmHg for the AAJT group. Mean blood loss at 5 minutes and mean total blood loss were greater in the CG group than in the AAJT group.
Conclusion: AAJT is superior to CG in controlling hemorrhage in a junctional wound in a swine model.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.55460/DIA2-IDCY | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Combined effect of intermittent hemostasis and a modified external hemorrhage control device in a lethal swine model.
Heliyon
September 2024
Department of Trauma Surgery, Medical Center of Trauma and War Injury, State Key Laboratory of Trauma, Burns and Combined Injuries, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Article Synopsis
- Researchers developed a new device called Modified EHCD (M-EHCD) to improve the control of non-compressible torso hemorrhage (NCTH) in emergency care, utilizing intermittent hemostasis to address potential tissue damage during blood flow restoration.
- In an experiment with 18 pigs, the M-EHCD was tested against two existing devices, the AAJT and SJT, showing faster application time and significantly less blood loss during hemorrhagic shock.
- Results indicated that M-EHCD not only effectively controlled bleeding but also led to better heart rate management and lower internal pressure changes compared to the other devices, potentially improving patient outcomes in real-life trauma scenarios.
Factors associated with SARS-CoV2 infection and care pathways among the most vulnerable populations living in Marseille: a case control study.
BMC Public Health
September 2021
Aix-Marseille University, School of Medicine - La Timone Medical Campus, Marseille, France.
Background: The Covid-19 pandemic has led to substantial and unexpected increases in morbidity and mortality in France. Vulnerable populations housed in accommodation centres have a greater risk of infection because collective housing and their dependence on social support services mean it is more difficult to apply preventive measures. They are also at greater risk of developing severe forms of Covid-19 and waiting longer before seeking healthcare (for Covid-19 or other) treatment.
View Article and Find Full Text PDFBackground: Two methods of controlling pelvic and inguinal hemorrhage are the Abdominal Aortic and Junctional Tourniquet (AAJT; Compression Works) and resuscitative endovascular balloon occlusion of the aorta (REBOA). The AAJT can be applied quickly, but prolonged use may damage the bowel, inhibit ventilation, and obstruct surgical access. REBOA requires technical proficiency but avoids many of the complications associated with the AAJT.
View Article and Find Full Text PDFEffect of the Abdominal Aortic and Junctional Tourniquet on chest compressions in a swine model of ventricular fibrillation.
Am J Emerg Med
July 2021
Office of the Chief Scientist, Wilford Hall Ambulatory Surgical Center, 59th Medical Wing, 2200; Bergquist Drive, Building 4550, JBSA-Lackland, TX 78236, United States of America. Electronic address:
Introduction: Mortality for out-of-hospital cardiac arrest is high when traditional chest compressions are used without adjuncts. The abdominal aortic and junctional tourniquet (AAJT) is a device with a wedge-shaped air bladder that occludes the aortic bifurcation, augmenting blood flow to the heart and brain. Previously, the addition of AAJT during chest compression led to an increase in rate of survival in a model of traumatic cardiac arrest.
View Article and Find Full Text PDFAbdominal aortic and junctional tourniquet versus zone III resuscitative endovascular balloon occlusion of the aorta in a swine junctional hemorrhage model.
J Trauma Acute Care Surg
February 2020
From the Department of Surgery, Brooke Army Medical Center (D.W.S., D.S.K.), JBSA Fort Sam Houston; Army Institute of Surgical Research (D.S.K., R.D.G., I.A.P., M.D.P., B.S.K., M.A.D.), JBSA Fort Sam Houston, Houston, Texas; and Department of Surgery, Uniformed Services University of the Health Sciences (D.S.K.), Bethesda, Maryland.
Background: Junctional hemorrhage is a leading contributor to battlefield mortality. The Abdominal Aortic and Junctional Tourniquet (AAJT) and infrarenal (zone III) resuscitative endovascular balloon occlusion of the aorta (REBOA) are emerging strategies for controlling junctional hemorrhage, with AAJT currently available in select forward deployed settings and increasing interest in applying REBOA in the military prehospital environment. This study compared the hemostatic, hemodynamic, and metabolic effects of these devices used for junctional hemorrhage control.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!